Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cassini Technologies is a private ophthalmic medical device company focused on corneal diagnostics, surgical planning, and digital workflow tools for cataract and refractive surgery. Its core offerings include Cassini Ambient for preoperative corneal measurement and image registration, and Cassini Connect O.R., a digital cataract surgery suite that links diagnostics, planning, and intraoperative guidance. The company’s technology is built around patented multicolor LED point-to-point ray tracing and registration algorithms designed to improve precision in toric intraocular lens alignment and astigmatism management. Cassini integrates with major femtosecond laser and operating room workflows and markets its products to vision-care providers globally. The business appears to be commercial-stage rather than therapeutics-focused, with revenue generated from ophthalmic devices and software solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cassini.